tetraethylenepentamine has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Asai, T; Dewa, T; Kato, H; Koide, H; Maeda, N; Nango, M; Oku, N; Yokota, M; Yonenaga, N | 1 |
| Ando, H; Asai, T; Dewa, T; Okamoto, A; Oku, N; Shimizu, K; Yokota, M | 1 |
2 other study(ies) available for tetraethylenepentamine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Proliferation; Ethylenediamines; Liposomes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphatidylethanolamines; Phosphorylation; Polyethylene Glycols; PTEN Phosphohydrolase; RNA, Small Interfering; TOR Serine-Threonine Kinases | 2015 |
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.
Topics: Angiogenesis Inhibitors; Blotting, Western; Cells, Cultured; Ethylenediamines; Gene Expression Regulation; Gene Knockdown Techniques; Gene Transfer Techniques; Human Umbilical Vein Endothelial Cells; Humans; Integrin alpha5; Liposomes; MAP Kinase Kinase 4; MicroRNAs; Microscopy, Confocal; Neoplasms; Neovascularization, Pathologic; Receptors, Lysosphingolipid; RNA Interference; Sphingosine-1-Phosphate Receptors | 2013 |